Flora Growth (FLGC) Revenue & Revenue Breakdown
Flora Growth Revenue Highlights
Latest Revenue (Y)
$59.51M
Latest Revenue (Q)
$11.79M
Main Segment (Y)
Pharmaceuticals and Nutraceuticals
Main Geography (Y)
GERMANY
Flora Growth Revenue by Period
Flora Growth Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $59.51M | -21.78% |
| 2023-12-31 | $76.07M | 104.65% |
| 2022-12-31 | $37.17M | 313.93% |
| 2021-12-31 | $8.98M | 8371.70% |
| 2020-12-31 | $106.00K | 100.00% |
| 2019-12-31 | - | - |
Flora Growth generated $59.51M in revenue during NA 2024, up -21.78% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Flora Growth Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $11.79M | -11.56% |
| 2024-12-31 | $13.33M | 6.91% |
| 2024-09-30 | $12.46M | -20.52% |
| 2024-06-30 | $15.68M | -13.02% |
| 2024-03-31 | $18.03M | 0.31% |
| 2023-12-31 | $17.98M | 3.80% |
| 2023-09-30 | $17.32M | -19.31% |
| 2023-06-30 | $21.46M | 6.73% |
| 2023-03-31 | $20.11M | 75.01% |
| 2022-12-31 | $11.49M | 6.73% |
| 2022-09-30 | $10.77M | 7.96% |
| 2022-06-30 | $9.97M | 101.60% |
| 2022-03-31 | $4.95M | 3.71% |
| 2021-12-31 | $4.77M | 127.85% |
| 2021-09-30 | $2.09M | 80.59% |
| 2021-06-30 | $1.16M | 9.44% |
| 2021-03-31 | $1.06M | 1898.11% |
| 2020-12-31 | $53.00K | - |
| 2020-09-30 | $53.00K | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-06-30 | - | - |
Flora Growth generated $11.79M in revenue during Q1 2025, up -11.56% compared to the previous quarter, and up 65.57% compared to the same period a year ago.
Flora Growth Revenue Breakdown
Flora Growth Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 21 |
|---|---|
| Pharmaceuticals and Nutraceuticals | $2.34M |
Flora Growth's latest annual revenue breakdown by segment (product or service), as of Dec 21: Pharmaceuticals and Nutraceuticals (100.00%).
Flora Growth Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 21 |
|---|---|---|---|
| AUSTRALIA | $671.00K | - | - |
| GERMANY | $35.87M | $38.26M | - |
| UNITED STATES | $22.24M | $36.54M | - |
| United States | - | - | $1.68M |
| Pharmaceuticals and Nutraceuticals | - | - | $2.34M |
| Canada | - | - | $380.00K |
Flora Growth's latest annual revenue breakdown by geography, as of Dec 24: GERMANY (61.02%), UNITED STATES (37.84%), and AUSTRALIA (1.14%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Jun 23 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | $4.39M | $4.66M | $10.88M | $4.84M | $6.52M | $26.18M | $10.35M |
| AUSTRALIA | $489.00K | $154.00K | $482.00K | $189.00K | - | - | - |
| GERMANY | $9.88M | $6.87M | $17.28M | $7.24M | $11.34M | $27.46M | $10.80M |
Flora Growth's latest quarterly revenue breakdown by geography, as of Jun 25: GERMANY (66.93%), UNITED STATES (29.76%), and AUSTRALIA (3.31%).
Flora Growth Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MRKR | Marker Therapeutics | $6.59T | $349.10K |
| FLGC | Flora Growth | $59.51M | $11.79M |
| TRIB | Trinity Biotech | $56.83M | $14.70M |
| BFRI | Biofrontera | $37.30M | $8.59M |
| BOLT | Bolt Biotherapeutics | $7.69M | $1.22M |
| EVGN | Evogene | $5.64M | $4.19M |
| SINT | Sintx | $2.89M | $369.00K |
| ABP | Abpro | $122.00K | - |
| TXMD | TherapeuticsMD | - | $952.00K |
| CHEK | Check-Cap | - | - |